AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 2,590.00
-60.00 (-2.26%)
At close: Jun 5, 2026
AriBioLab Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -15,544 | -16,044 | -10,138 | -1,749 | -6,715 | -18,420 |
Depreciation & Amortization | 442.47 | 455.64 | 491.22 | 533.31 | 417.36 | 245.49 |
Loss (Gain) From Sale of Investments | -211.45 | -263.18 | -66.77 | 40.4 | -105.84 | -125.77 |
Stock-Based Compensation | 2.09 | 68.7 | 61.53 | 118.92 | 444.39 | 451.81 |
Other Operating Activities | 3,772 | 3,708 | 3,789 | -2,286 | 1,240 | 12,783 |
Change in Other Net Operating Assets | 950.82 | 1,059 | -2,232 | -1,951 | -469.56 | 325.6 |
Operating Cash Flow | -10,588 | -11,017 | -8,096 | -5,293 | -5,189 | -4,740 |
Capital Expenditures | -36.1 | -116.84 | -179.21 | -278.58 | -447.4 | -679.57 |
Sale of Property, Plant & Equipment | 0.88 | 0.88 | - | - | - | - |
Sale (Purchase) of Intangibles | -37.89 | -39.08 | -55.37 | -12.21 | - | -3.66 |
Investment in Securities | 21,338 | 15,838 | 2,648 | 22,221 | 4,184 | -46,780 |
Other Investing Activities | 36.87 | 34.65 | -121.79 | - | -0 | - |
Investing Cash Flow | 21,301 | 15,718 | 2,291 | 21,930 | 3,736 | -47,463 |
Long-Term Debt Issued | - | - | 10,000 | 10,000 | - | - |
Total Debt Issued | - | - | 10,000 | 10,000 | - | - |
Long-Term Debt Repaid | - | -5,105 | -209.64 | -23,671 | -116.29 | -116.29 |
Total Debt Repaid | -10,681 | -5,105 | -209.64 | -23,671 | -116.29 | -116.29 |
Net Debt Issued (Repaid) | -10,681 | -5,105 | 9,790 | -13,671 | -116.29 | -116.29 |
Issuance of Common Stock | 87.38 | 87.38 | 199.9 | 554.71 | - | 44,436 |
Other Financing Activities | - | - | -0 | -0 | - | - |
Financing Cash Flow | -10,593 | -5,018 | 9,990 | -13,117 | -116.29 | 44,320 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | 0.17 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | -0 | - | - |
Net Cash Flow | 120 | -317.26 | 4,186 | 3,520 | -1,568 | -7,883 |
Free Cash Flow | -10,624 | -11,134 | -8,275 | -5,572 | -5,636 | -5,419 |
Free Cash Flow Margin | -3202.26% | -7019.41% | -2232.46% | -1894.38% | -3140.08% | -1083.83% |
Free Cash Flow Per Share | -395.19 | -414.59 | -308.52 | -210.20 | -213.18 | -232.41 |
Cash Income Tax Paid | - | -64.87 | -168.01 | 288.65 | 85.97 | 17.07 |
Levered Free Cash Flow | -7,619 | -5,931 | -2,183 | -10,251 | -6,799 | -6,029 |
Unlevered Free Cash Flow | -6,314 | -4,586 | -1,378 | -8,607 | -5,195 | -4,703 |
Change in Working Capital | 950.82 | 1,059 | -2,232 | -1,951 | -469.56 | 325.6 |